213 related articles for article (PubMed ID: 25023274)
1. Review: voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia.
Morris AM
Ann Intern Med; 2014 Jul; 161(2):JC8. PubMed ID: 25023274
[No Abstract] [Full Text] [Related]
2. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Johnson JR
N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12037157
[No Abstract] [Full Text] [Related]
6. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Ullmann AJ; Heussel CP; Cornely OA
N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
[No Abstract] [Full Text] [Related]
7. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
Powers JH; Dixon CA; Goldberger MJ
N Engl J Med; 2002 Jan; 346(4):289-90. PubMed ID: 11807157
[No Abstract] [Full Text] [Related]
8. [Current indications for voriconazole in onco-hematological patients].
Jarque I; Sanz MA
Rev Iberoam Micol; 2007 Sep; 24(3):213-6. PubMed ID: 17874858
[TBL] [Abstract][Full Text] [Related]
9. Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
Klastersky J
N Engl J Med; 2004 Sep; 351(14):1445-7. PubMed ID: 15459307
[No Abstract] [Full Text] [Related]
10. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient.
Vincent AL; Cabrero JE; Greene JN; Sandin RL
Cancer Control; 2003; 10(5):414-9. PubMed ID: 14581897
[No Abstract] [Full Text] [Related]
11. Decisions about voriconazole versus liposomal amphotericin B.
Walsh TJ; Lee J; Dismukes WE
N Engl J Med; 2002 May; 346(19):1499; author reply 1499. PubMed ID: 12000825
[No Abstract] [Full Text] [Related]
12. Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Guitard J; Degulys A; Buot G; Aline-Fardin A; Dannaoui E; Rio B; Marie JP; Lapusan S; Hennequin C
Clin Microbiol Infect; 2014 Jan; 20(1):O30-2. PubMed ID: 23991697
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
Chamilos G; Kontoyiannis DP
J Infect; 2005 Nov; 51(4):e225-8. PubMed ID: 16291275
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
Pagano L; Valentini CG; Fianchi L; Caira M
J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486
[TBL] [Abstract][Full Text] [Related]
15. Empirical antifungal therapy--new options, new tradeoffs.
Marr KA
N Engl J Med; 2002 Jan; 346(4):278-80. PubMed ID: 11807153
[No Abstract] [Full Text] [Related]
16. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Apisarnthanarak A; Little JR; Tebas P
N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041527
[No Abstract] [Full Text] [Related]
17. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
18. [Clinical cases in medical mycology. Case no. 21].
Negroni R; López Daneri G; Robles AM; Arechavala A; Bianchi MH; Santiso G
Rev Iberoam Micol; 2006 Jun; 23(2):119-21. PubMed ID: 16854193
[No Abstract] [Full Text] [Related]
19. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Chiou CC; Groll AH; Walsh TJ
Oncologist; 2000; 5(2):120-35. PubMed ID: 10794803
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin versus liposomal amphotericin B for empirical therapy.
Danaher PJ
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
[No Abstract] [Full Text] [Related]
[Next] [New Search]